|Videos|July 31, 2020
Sponsored: The Lens Care System I Trust
Dr. Chris Lievens
Advertisement
References
Take the Time…
- Gabriel MM, Bartell J, Walters R, et al. Biocidal efficacy of a new hydrogen peroxide contact lens care system against bacteria, fungi, and Acanthamoeba species. Optom Vis Sci. 2014;91:E-abstract 145192.
- Gabriel MM, McAnally C, Bartell J, et al. Biocidal efficacy of a hydrogen peroxide lens care solution incorporating a novel wetting agent. Eye Contact Lens. 2019;45(3):164-170.
- Alcon data on file, 2016.
- Alcon data on file, 2016.
What patients are asking…
- Alcon data on file, 2014.
- Gabriel M, Bartell J, Walters R, et al. Biocidal efficacy of a new hydrogen peroxide contact care lens system against bacteria, fungi, and Acanthamoeba species. Optom Vis Sci. 2014;91:E-abstract 145192.
- Gabriel MM, McAnally C, Bartell J, et al. Biocidal efficacy of a hydrogen peroxide lens care solution incorporating a novel wetting agent. Eye Contact Lens. 2019;45(3):164-170.
Compliance made simple…
- Dumbleton K, Woods J, Woods C, Fonn D. Compliance with current contact lens care regimens. Optom Vis Sci. 2007;84:E-abstract 070087.
- Guthrie S, Dumbleton K, Jones L. Contact Lens Compliance. Contact Lens Spectrum. 2016;31:40-43.
- Woods J, Srinivasan S, Jones L. Compliance with the use of hydrogen peroxide and multipurpose solution care regimens. Contact Lens Spectrum. In press.
My #1 choice…
- Alcon data on file, 2014.
- Gabriel M, Bartell J, Walters R, et al. Biocidal efficacy of a new hydrogen peroxide contact care lens system against bacteria, fungi, and Acanthamoeba species. Optom Vis Sci. 2014;91:E-abstract 145192.
© 2020 Alcon Inc. 7/20 US-CCP-2000006
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
How to put wearable virtual reality technology to work in your practice
2
Spotlight on human trafficking: A virtual epidemic in the US
3
Phase 1 trial findings confirm safety and tolerability of Huons’ dry eye therapy
4
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
5











































.png)


